enow.com Web Search

  1. Ads

    related to: glioblastoma multiforme gbm grade 4 tumor marker

Search results

  1. Results from the WOW.Com Content Network
  2. Glioblastoma - Wikipedia

    en.wikipedia.org/wiki/Glioblastoma

    Glioblastoma, previously known as glioblastoma multiforme (GBM), is the most aggressive and most common type of cancer that originates in the brain, and has a very poor prognosis for survival. [ 6 ] [ 7 ] [ 8 ] Initial signs and symptoms of glioblastoma are nonspecific. [ 1 ]

  3. Gliosarcoma - Wikipedia

    en.wikipedia.org/wiki/Gliosarcoma

    Gliosarcoma is a malignant cancer, and is defined as a glioblastoma consisting of gliomatous and sarcomatous components. [3] Primary gliosarcoma (PGS) is classified as a grade IV tumor and a subtype of glioblastoma multiforme in the 2007 World Health Organization classification system (GBM). [4]

  4. Neuro-oncology - Wikipedia

    en.wikipedia.org/wiki/Neuro-oncology

    Neuro-oncology is the study of brain and spinal cord neoplasms, many of which are (at least eventually) very dangerous and life-threatening (astrocytoma, glioma, glioblastoma multiforme, ependymoma, pontine glioma, and brain stem tumors are among the many examples of these).

  5. TNM staging system - Wikipedia

    en.wikipedia.org/wiki/TNM_staging_system

    G (1–4): the grade of the cancer cells (i.e. they are "low grade" if they appear similar to normal cells, and "high grade" if they appear poorly differentiated) S (0–3): elevation of serum tumor markers; R (0–2): the completeness of the operation (resection-boundaries free of cancer cells or not) Pn (0–1): invasion into adjunct nerves

  6. The Cancer Genome Atlas - Wikipedia

    en.wikipedia.org/wiki/The_Cancer_Genome_Atlas

    Three tumor types were explored during the pilot phase, glioblastoma multiforme (GBM) and high-grade serous ovarian adenocarcinoma, and lung squamous carcinoma. Following success of the pilot phase, TCGA expanded its effort to characterize additional cancer types and provide a rich and large genomic data set for further cancer research discovery.

  7. WHO classification of tumours of the central nervous system

    en.wikipedia.org/wiki/WHO_classification_of...

    1.2.3 Polymorphous low-grade neuroepithelial tumor of the young (PLNTY) 1.2.4 Diffuse low-grade glioma, MAPK pathway-altered 1.3 Pediatric-type diffuse high-grade gliomas 1.3.1 Diffuse midline glioma, H3 K27-altered 1.3.2 Diffuse hemispheric glioma, H3 G34-mutant 1.3.3 Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype 1.3.4 ...

  8. U-87 MG - Wikipedia

    en.wikipedia.org/wiki/U-87_MG

    Formally known as U-87 MG (abbreviation for Uppsala 87 Malignant Glioma), the U87 cell line has an epithelial morphology and was obtained from a 44-year-old female patient in 1966 at Uppsala University. The cell line was thought to be deposited at the Memorial Sloan Kettering Cancer Center in 1973, after which the ATCC obtained it in 1982. [2]

  9. OLIG2 - Wikipedia

    en.wikipedia.org/wiki/OLIG2

    OLIG2 is well recognized for its importance in cancer research, particularly in brain tumors and leukemia.OLIG2 is universally expressed in glioblastoma and other diffuse gliomas (astrocytomas, oligodendrogliomas and oligoastrocytomas), and is a useful positive diagnostic marker of these brain tumors. [13]

  1. Ads

    related to: glioblastoma multiforme gbm grade 4 tumor marker